cannabis indica

Índice completo — página 69 de 77

Estudos 6.801 a 6.900 de 7.640, ordenados do mais recente ao mais antigo — nesta página, publicações de 2008 a 2007. Para buscar por termo ou combinar filtros, use o acervo com busca.

Estudos 6.801 a 6.900

  1. 2008

    Long-term effect of CB1 blockade with rimonabant on cardiometabolic risk factors: two year results from the RIO-Europe Study

    FavorávelEnsaio Clínico Duplo-CegoObesidade
  2. 2008

    Loss of Cannabinoid Receptor 1 Accelerates Intestinal Tumor Growth

    FavorávelEstudo em AnimaisCâncerCâncer — Cólon
  3. 2008

    Low doses of cannabinoids enhance the antinociceptive effects of intracisternally-administered mGluRs groups II and III agonists in formalin-induced TMJ nociception in rats

    FavorávelEstudo em AnimaisDisfunção Temporomandibular (DTM)Canabinoides Sintéticos WIN-x
  4. 2008

    Management of bone metastases

    FavorávelMetanáliseDorCâncerCâncer — MamaTHC:CBD Farmacêutico+9
  5. 2008

    Mediation of Cannabidiol anti-inflammation in the Retina by Equilibrative Nucleoside Transporter and A2A Adenosine Receptor.

    FavorávelEstudo em AnimaisDoenças da Retina
  6. 2008

    Multiple-dose pharmacokinetics, pharmacodynamics, and safety of taranabant, a novel selective cannabinoid-1 receptor inverse agonist, in healthy male volunteers

    DesfavorávelEnsaio ClínicoObesidadeCanabinoide Sintético (não especificado)
  7. 2008

    Nabilone for the treatment of pain in fibromyalgia.

    FavorávelEnsaio Clínico Duplo-CegoFibromialgiaTetraidrocanabinol (THC)
  8. 2008

    Nabilone For The Treatment Of Paraneoplastic Night Sweats: A Report Of Four Cases

    FavorávelMetanáliseSudorese Noturna e Excessiva
  9. 2008

    Neural Basis Of Delta-9-tetrahydrocannabinol And Cannabidiol: Effects During Response Inhibition

    FavorávelEnsaio Clínico Duplo-CegoDependência — Nicotina
  10. 2008

    Neurocognitive performance during acute THC intoxication in heavy and occasional cannabis users

    DesfavorávelEnsaio Clínico Duplo-CegoDisfunção Cognitiva
  11. 2008

    Neuroprotective effects of the nonpsychoactive cannabinoid cannabidiol in hypoxic-ischemic newborn piglets

  12. 2008

    Nicotine (NC)-induced "depressive" behavioral symptoms and effects of antidepressants including cannabinoids (CBs)

  13. 2008

    Non-cannabinoid constituents from a high potency Cannabis sativa variety.

    FavorávelEstudo LaboratorialInfecção por EstafilococosMaláriaLeishmaniose
  14. 2008

    Obesity in adults

    DesfavorávelMetanálise ClínicaObesidadeCanabinoides Sintéticos SR-x
  15. 2008

    Open-Label, Add-on Study of Tetrahydrocannabinol for Chronic Nonmalignant Pain

  16. 2008

    Oral nabilone capsules in the treatment of chemotherapy-induced nausea and vomiting and pain

  17. 2008

    Patients with chronic pain on opioid therapy taking dronabinol: incidence of false negatives using radioimmunoassay

    DesfavorávelEnsaio ClínicoDorDor — CrônicaTHC Farmacêutico
  18. 2008

    Peripheral endocannabinoid system activity in patients treated with sibutramine

    DesfavorávelEnsaio Clínico Duplo-CegoObesidadeAnandamida (AEA)2-Araquidonoilglicerol (2-AG)
  19. 2008

    Peroxisome Proliferator-Activated Receptors: “Key” Regulators of Neuroinflammation after Traumatic Brain Injury

  20. 2008

    Pharmacokinetics and tissue distribution of the sesquiterpene alpha-humulene in mice.

    FavorávelEstudo em AnimaisDorDor — Polineuropatia Inflamatória
  21. 2008

    Pharmacotherapeutic targeting of the endocannabinoid signaling system: Drugs for obesity and the metabolic syndrome

  22. 2008

    Phytochemical Analysis and in Vitro Antiviral Activities of the Essential Oils of Seven Lebanon Species

    FavorávelEstudo LaboratorialDoenças Priônicas
  23. 2008

    Preliminary results from a phase I/II study of perillyl alcohol intranasal administration in adults with recurrent malignant gliomas.

    FavorávelEnsaio ClínicoCâncerCâncer — Cérebro
  24. 2008

    Prolonged glucocorticoid treatment decreases cannabinoid CB1 receptor density in the hippocampus

    InconclusivoEstudo em AnimaisMedicina Mente-Corpo
  25. 2008

    Protective effect of linalool, myrcene and eucalyptol against t-butyl hydroperoxide induced genotoxicity in bacteria and cultured human cells

    FavorávelEstudo LaboratorialCâncerEstresse Oxidativo
  26. 2008

    Psychosocial interventions for people with both severe mental illness and substance misuse

    DesfavorávelMetanálise ClínicaDependência Química
  27. 2008

    Reciprocal influences of CB1 cannabinoid receptor agonists on ERK and JNK signalling in N1E-115 cells

  28. 2008

    Regulation of endocannabinoid signaling by stress: implications for stress-related affective disorders.

    FavorávelMetanáliseDepressãoEndocanabinoide (não especificado)
  29. 2008

    Role Of Cannabinoid Receptors In Bone Disorders: Alternatives For Treatment

    FavorávelMetanáliseCâncerArtriteArtrite — Reumatoide+2
  30. 2008

    Role of cannabinoids in chronic liver diseases

  31. 2008

    Role of the endocannabinoid system in regulation of the hypothalamic-pituitary-adrenocortical axis.

    FavorávelMetanáliseEndocanabinoide (não especificado)
  32. 2008

    Safety, tolerability, pharmacokinetics, and pharmacodynamic properties of taranabant, a novel selective cannabinoid-1 receptor inverse agonist, for the treatment of obesity: results from a double-blind, placebo-controlled, single oral dose study in healthy volunteers

    InconclusivoEnsaio Clínico Duplo-CegoObesidade
  33. 2008

    Sensitization and allergy to Cannabis sativa leaves in a population of tomato (Lycopersicon esculentum)-sensitized patients

    InconclusivoEnsaio ClínicoAlergia à Cannabis
  34. 2008

    SERENADE: the Study Evaluating Rimonabant Efficacy in Drug-naive Diabetic Patients: effects of monotherapy with rimonabant, the first selective CB1 receptor antagonist, on glycemic control, body weight, and lipid profile in drug-naive type 2 diabetes

    InconclusivoEnsaio Clínico Duplo-CegoDiabetesCanabinoide Sintético (não especificado)
  35. 2008

    Suppression of human macrophage interleukin-6 by a nonpsychoactive cannabinoid acid.

    FavorávelEstudo LaboratorialInflamaçãoArtriteArtrite — Reumatoide+1
  36. 2008

    Targeted Deletion of Cannabinoid Receptors CB1 and CB2 Produced Enhanced Inflammatory Responses to Influenza A/PR/8/34 in the Absence and Presence of Delta9-tetrahydrocannabinol

    InconclusivoEstudo em AnimaisInflamaçãoGripe
  37. 2008

    Targeting endocannabinoid degradation protects against experimental colitis in mice: involvement of CB1 and CB2 receptors.

  38. 2008

    Targeting the endocannabinoid system: to enhance or reduce?

  39. 2008

    The Cannabinoid Antagonist AM251 Attenuates Nicotine Self-administration And Nicotine-seeking Behaviour In Rats

  40. 2008

    The cannabinoid CP55,940 prolongs survival and improves locomotor activity in Drosophila melanogaster against paraquat: implications in Parkinson's disease

    FavorávelEstudo em AnimaisDoença de ParkinsonCanabinoides Sintéticos WIN-x
  41. 2008

    The Cannabinoid Receptor Agonist Nabilone For The Treatment Of Dementia-related Agitation

    FavorávelMetanáliseDoença de AlzheimerTHC Farmacêutico
  42. 2008

    The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: Δ9-tetrahydrocannabinol, cannabidiol and Δ9-tetrahydrocannabivarin

    InconclusivoMetanáliseCanabigerol (CBG)Tetraidrocanabivarina (THCV)+1
  43. 2008

    The Effects of Cannabidiol and Tetrahydrocannabinol on Motion‐Induced Emesis in Suncus murinus.

  44. 2008

    The endocannabinoid system as a novel target for the treatment of liver fibrosis.

  45. 2008

    The influence of mast cell mediators on migration of SW756 cervical carcinoma cells

  46. 2008

    The nonpsychoactive Cannabis constituent cannabidiol is a wake-inducing agent

    FavorávelEstudo em AnimaisInsônia e Distúrbios do Sono
  47. 2008

    The phytocannabinoid Delta(9)-tetrahydrocannabivarin modulates inhibitory neurotransmission in the cerebellum

    FavorávelEstudo LaboratorialEpilepsiaTetraidrocanabivarina (THCV)
  48. 2008

    The Role Of The Endocannabinoid System In Alzheimer's Disease: Facts And Hypotheses

    FavorávelMetanáliseDoença de Alzheimer
  49. 2008

    The role of the endocannabinoid system in the regulation of hypothalamic-pituitary-adrenal axis activity

  50. 2008

    Therapeutic use of Cannabis sativa on chemotherapy-induced nausea and vomiting among cancer patients: systematic review and meta-analysis

    FavorávelMetanálise ClínicaNáusea e Vômito por QuimioterapiaTHC Farmacêutico
  51. 2008

    Ulcerative colitis in AKR mice is attenuated by intraperitoneally administered anandamide

  52. 2008

    Use of Cannabinoids in Palliative Medicine

    FavorávelMetanáliseCuidados Paliativos
  53. 2008

    Use of dronabinol for cannabis dependence: two case reports and review

  54. 2008

    Virodhamine relaxes the human pulmonary artery through the endothelial cannabinoid receptor and indirectly through a COX product

  55. 2007

    A Novel Role of Cannabinoids: Implication in the Fever Induced by Bacterial Lipopolysaccharide.

    FavorávelEstudo em AnimaisCanabinoides Sintéticos WIN-xCanabinoides Sintéticos SR-x
  56. 2007

    Acute cannabis intoxication mimicking brugada-like ST segment abnormalities

  57. 2007

    Acute effects of Delta9-tetrahydrocannabinol and standardized cannabis extract on the auditory evoked mismatch negativity

    FavorávelEnsaio ClínicoTetraidrocanabinol (THC)
  58. 2007

    Agonist selective modulation of tyrosine hydroxylase expression by cannabinoid ligands in a murine neuroblastoma cell line

    InconclusivoEstudo LaboratorialCâncerCâncer — NeuroblastomaTetraidrocanabinol (THC)
  59. 2007

    Alzheimer's disease; taking the edge off with cannabinoids?

    FavorávelMetanáliseDoença de Alzheimer
  60. 2007

    Anorexia of aging in long term care: is dronabinol an effective appetite stimulant?--a pilot study.

  61. 2007

    Anti-inflammatory effects of compounds alpha-humulene and (-)-trans-caryophyllene isolated from the essential oil of Cordia verbenacea.

    FavorávelEstudo em AnimaisInflamação
  62. 2007

    Anti‐inflammatory property of the cannabinoid receptor‐2‐selective agonist JWH‐133 in a rodent model of autoimmune uveoretinitis

    FavorávelEstudo em AnimaisUveíteCanabinoides Sintéticos JWH-x
  63. 2007

    Anticoagulant effects of a Cannabis extract in an obese rat model

    FavorávelEstudo em AnimaisDistúrbios de CoagulaçãoCanabinol (CBN)
  64. 2007

    Antifungal effect of eugenol and nerolidol against Microsporum gypseum in a guinea pig model.

    FavorávelEstudo em AnimaisDoenças de PeleInfecções Fúngicas
  65. 2007

    Arvanil, anandamide and N-arachidonoyl-dopamine (NADA) inhibit emesis through cannabinoid CB1 and vanilloid TRPV1 receptors in the ferret

  66. 2007

    Atrial Fibrillation and Marijuana Smoking

    DesfavorávelMetanáliseDoenças Cardiovasculares (DCV)Fibrilação Atrial
  67. 2007

    Attenuation of Allergic Contact Dermatitis Through the Endocannabinoid System.

    FavorávelEstudo em AnimaisDermatite de Contato AlérgicaAnandamida (AEA)Tetraidrocanabinol (THC)+4
  68. 2007

    Bidirectional alterations of hippocampal cannabinoid 1 receptors and their endogenous ligands in a rat model of alcohol withdrawal and dependence

  69. 2007

    Blockade of central cyclooxygenase (COX) pathways enhances the cannabinoid-induced antinociceptive effects on inflammatory temporomandibular joint (TMJ) nociception

    FavorávelEstudo em AnimaisDisfunção Temporomandibular (DTM)Canabinoides Sintéticos WIN-x
  70. 2007

    Cannabidiol As A Novel Inhibitor Of Id-1 Gene Expression In Aggressive Breast Cancer Cells

    FavorávelEstudo LaboratorialCâncerCâncer — Mama
  71. 2007

    Cannabidiol reduced the striatal atrophy caused 3-nitropropionic acid in vivo by mechanisms independent of the activation of cannabinoid, vanilloid TRPV1 and adenosine A2A receptors.

  72. 2007

    Cannabidiol, a nonpsychoactive Cannabis constituent, protects against myocardial ischemic reperfusion injury.

    FavorávelEstudo em AnimaisDoenças Cardiovasculares (DCV)InfartoLesão de Reperfusão+2
  73. 2007

    Cannabidiol, unlike synthetic cannabinoids, triggers activation of RBL-2H3 mast cells

    FavorávelEstudo LaboratorialSíndrome de Ativação Mastocitária
  74. 2007

    Cannabinoid activation of PPAR alpha; a novel neuroprotective mechanism

    FavorávelEstudo LaboratorialVirodamina (O-AEA)
  75. 2007

    Cannabinoid modulation of Kaposi's sarcoma-associated herpesvirus infection and transformation.

    DesfavorávelEstudo LaboratorialSarcoma de Kaposi
  76. 2007

    Cannabinoid receptor-mediated translocation of NO-sensitive guanylyl cyclase and production of cyclic GMP in neuronal cells

    InconclusivoEstudo LaboratorialCâncerCâncer — Neuroblastoma
  77. 2007

    Cannabinoid type 1 receptor antagonists (rimonabant) for smoking cessation

    DesfavorávelMetanálise ClínicaDependência QuímicaDependência — NicotinaCanabinoides Sintéticos SR-x
  78. 2007

    Cannabinoid type 1 receptor antagonists (rimonabant) for smoking cessation

    DesfavorávelMetanálise ClínicaDependência QuímicaDependência — NicotinaCanabinoides Sintéticos SR-x
  79. 2007

    Cannabinoid Type 1 Receptor Modulates Intestinal Propulsion by an Attenuation of Intestinal Motor Responses Within the Myenteric Part of the Peristaltic Reflex

  80. 2007

    Cannabinoid-2 receptor mediates protection against hepatic ischemia/reperfusion injury.

    FavorávelEstudo em AnimaisInsuficiência HepáticaAnandamida (AEA)2-Araquidonoilglicerol (2-AG)+3
  81. 2007

    Cannabinoid-induced pancreatitis: a case series

    DesfavorávelMetanálisePancreatite
  82. 2007

    Cannabinoids ameliorate cerebral dysfunction following liver failure via AMP-activated protein kinase

  83. 2007

    Cannabinoids and cardiovascular disease: the outlook for clinical treatments.

    FavorávelMetanáliseDoenças Cardiovasculares (DCV)Hipertensão Arterial
  84. 2007

    Cannabinoids and neuroprotection in basal ganglia disorders.

    FavorávelMetanáliseInflamaçãoDoenças Cardiovasculares (DCV)Estresse Oxidativo+5
  85. 2007

    Cannabinoids Elicit Antidepressant-Like Behavior and Activate Serotonergic Neurons through the Medial Prefrontal Cortex.

    FavorávelEstudo em AnimaisDepressãoCanabinoides Sintéticos WIN-x
  86. 2007

    Cannabinoids in health and disease

  87. 2007

    Cannabinoids induce glioma stem-like cell differentiation and inhibit gliomagenesis

  88. 2007

    Cannabinoids mediate analgesia largely via peripheral type 1 cannabinoid receptors in nociceptors.

  89. 2007

    Cannabinoids:their Role in Pain and Palliation

    FavorávelMetanáliseCuidados Paliativos
  90. 2007

    Cannabis and Ecstasy/MDMA (3,4-methylenedioxymethamphetamine): an analysis of their neuropsychobiological interactions in recreational users.

    FavorávelMetanáliseEstresse OxidativoEfeitos Adversos do MDMA
  91. 2007

    Cannabis In Painful HIV-associated Sensory Neuropathy: A Randomized Placebo-controlled Trial

    FavorávelEnsaio Clínico Duplo-CegoDorDor — Neuropatia PeriféricaHIV/AIDSTetraidrocanabinol (THC)
  92. 2007

    Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review

    DesfavorávelMetanálise ClínicaPsicose
  93. 2007

    Cannabis, pain, and sleep: lessons from therapeutic clinical trials of Sativex, a cannabis-based medicine

  94. 2007

    Combined immunomodulating properties of 3,4-methylenedioxymethamphetamine (MDMA) and cannabis in humans

    DesfavorávelEnsaio ClínicoEfeitos Adversos da CannabisEfeitos Adversos do MDMA
  95. 2007

    Control of Spasticity in a Multiple Sclerosis Model is mediated by CB1, not CB2, Cannabinoid Receptors.

  96. 2007

    Damage To The Insula Disrupts Addiction To Cigarette Smoking

    FavorávelMetanáliseDependência QuímicaDependência — Nicotina
  97. 2007

    Delayed treatment with cannabidiol has a cerebroprotective action via a cannabinoid receptor‐independent myeloperoxidase‐inhibiting mechanism.

  98. 2007

    Delta9-tetrahydrocannabinol (Delta9-THC) prevents cerebral infarction via hypothalamic-independent hypothermia.

    FavorávelEstudo em AnimaisAVCEpilepsia — FIRESCanabinoides Sintéticos SR-x
  99. 2007

    Does occasional cannabis use impact anxiety and depression treatment outcomes?: Results from a randomized effectiveness trial

    DesfavorávelEnsaio ClínicoAnsiedadeDepressãoTetraidrocanabinol (THC)
  100. 2007

    Dose-dependent Effects of Smoked Cannabis on Capsaicin-Induced Pain and Hyperalgesia in Healthy Volunteers

    InconclusivoEnsaio Clínico Duplo-CegoDorDor — AgudaCapsaicina (CAPS)